Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis

Bibliography

• Kaikkonen MU, Lam MT, Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 2011;90:430-40
   PubMed Web of Science ®Google Scholar
• d’Adda di Fagagna F. A direct role for small non-coding RNAs in DNA damage response. Trends Cell Biol 2014;24:171-8
   PubMed Web of Science ®Google Scholar
• Peters T, Schroen B. Missing links in cardiology: long non-coding RNAs enter the arena. Pflugers Arch 2014;466(6):1177-87
   PubMed Web of Science ®Google Scholar
• Orenes-Pinero E, Montoro-Garcia S, Patel JV, et al. Role of microRNAs in cardiac remodelling: new insights and future perspectives. Int J Cardiol 2013;167:1651-9
   PubMed Web of Science ®Google Scholar
• Barker PC, Pasquali SK, Darty S, et al. Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy. Mol Genet Metab 2010;101:332-7
   PubMedGoogle Scholar
• Grossniklaus U, Kelly WG, Ferguson-Smith AC, et al. Transgenerational epigenetic inheritance: how important is it? Nat Rev Genetics 2013;14:228-35
   PubMed Web of Science ®Google Scholar
• Sharma A. Transgenerational epigenetic inheritance: focus on soma to germline information transfer. Prog Biophys Mol Biol 2013;113:439-46
   Google Scholar
• Viereck J, Bang C, Foinquinos A, et al. Regulatory RNAs and paracrine networks in the heart. Cardiovasc Res 2014;102:290-301
   PubMed Web of Science ®Google Scholar
• Jazbutyte V, Fiedler J, Kneitz S, et al. MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age (Dordr) 2013;35:747-62
   PubMed Web of Science ®Google Scholar
• Rothbart SB, Strahl BD. Interpreting the language of histone and DNA modifications. Biochim Biophys Acta 2014;1839(8):627-43
   PubMed Web of Science ®Google Scholar
• Leung D, Du T, Wagner U, et al. Regulation of DNA methylation turnover at LTR retrotransposons and imprinted loci by the histone methyltransferase Setdb1. Proc Natl Acad Sci USA 2014;111:6690-5
   PubMed Web of Science ®Google Scholar
• Reddy MA, Natarajan R. Role of epigenetic mechanisms in the vascular complications of diabetes. Subcell Biochem 2013;61:435-54
   PubMedGoogle Scholar
• Tao H, Yang JJ, Chen ZW, et al. DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2. Toxicology 2014;323C:42-50
   Google Scholar
• Ketzer P, Kaufmann JK, Engelhardt S, et al. Artificial riboswitches for gene expression and replication control of DNA and RNA viruses. Proc Natl Acad Sci USA 2014;111:E554-62
   PubMed Web of Science ®Google Scholar
• Kumar B, Kumar P, Rajput R, et al. Sequence-specific cleavage of BM2 gene transcript of influenza B virus by 10-23 catalytic motif containing DNA enzymes significantly inhibits viral RNA translation and replication. Nucleic Acid Ther 2013;23:355-62
   PubMedGoogle Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genetics 2014;15:7-21
   PubMed Web of Science ®Google Scholar
• Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res 2012;111:1349-62
   PubMed Web of Science ®Google Scholar
• Fan D, Takawale A, Basu R, et al. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction. Cardiovasc Res 2014;103(2):268-80
   PubMedGoogle Scholar
• de Haas HJ, Arbustini E, Fuster V, et al. Molecular imaging of the cardiac extracellular matrix. Circ Res 2014;114:903-15
   PubMedGoogle Scholar
• Sun G, Xue R, Yao F, et al. The critical role of Sestrin 1 in regulating the proliferation of cardiac fibroblasts. Arch Biochem Biophys 2014;542:1-6
   PubMedGoogle Scholar
• Gaspard GJ, MacLean J, Rioux D, et al. A novel beta-adrenergic response element regulates both basal and agonist-induced expression of cyclin-dependent kinase 1 gene in cardiac fibroblasts. Am J Physiol Cell Physiol 2014;306:C540-50
   Google Scholar
• Lu D, Aroonsakool N, Yokoyama U, et al. Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis. Mol Pharmacol 2013;84:787-93
   PubMedGoogle Scholar
• Zhang X, Guo L, Niu T, et al. Ubiquitin carboxyl terminal hydrolyase L1 -suppressed autophagic degradation of p21WAF1/Cip1 as a novel feedback mechanism in the control of cardiac fibroblast proliferation. PLoS One 2014;9:e94658
   Google Scholar
• Zhang X, Zhang T, Wu J, et al. Calcium sensing receptor promotes cardiac fibroblast proliferation and extracellular matrix secretion. Cell Physiol Biochem 2014;33:557-68
   PubMedGoogle Scholar
• Deb A, Ubil E. Cardiac fibroblast in development and wound healing. J Mol Cell Cardiol 2014;70C:47-55
   Web of Science ®Google Scholar
• Cilvik SN, Wang JI, Lavine KJ, et al. Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy. PLoS One 2013;8:e82979
   PubMed Web of Science ®Google Scholar
• Chen W, Saxena A, Li N, et al. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler Thromb Vasc Biol 2012;32:2598-608
   PubMed Web of Science ®Google Scholar
• Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 2014;71:549-74
   PubMed Web of Science ®Google Scholar
• Dobaczewski M, Frangogiannis NG. Chemokines and cardiac fibrosis. Front Biosci (Schol Ed) 2009;1:391-405
   PubMedGoogle Scholar
• van Nieuwenhoven FA, Turner NA. The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vascul Pharmacol 2013;58:182-8
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res 2012;110:159-73
   PubMed Web of Science ®Google Scholar
• Katsushima K, Kondo Y. Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation. Front Genet 2014;5:14
   PubMedGoogle Scholar
• Iaconetti C, Gareri C, Polimeni A, et al. Non-coding RNAs: the “dark matter” of cardiovascular pathophysiology. Int J Mol Sci 2013;14:19987-20018
   PubMed Web of Science ®Google Scholar
• Ounzain S, Crippa S, Pedrazzini T. Small and long non-coding RNAs in cardiac homeostasis and regeneration. Biochim Biophys Acta 2013;1833:923-33
   PubMed Web of Science ®Google Scholar
• Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011;10:38
   PubMed Web of Science ®Google Scholar
• Song X, Cao G, Jing L, et al. Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis. J Cell Mol Med 2014;18(6):991-1003
   PubMed Web of Science ®Google Scholar
• Shi L, Zhang Z, Yu AM, et al. The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs. PLoS One 2014;9:e93846
   PubMed Web of Science ®Google Scholar
• Patel T. Extracellular vesicle non-coding RNA - new players in the diagnosis and pathogenesis of cholangiocarcinoma. Hepatology 2014;60(3):782-4
   PubMedGoogle Scholar
• Merchen TD, Boesen EI, Gardner JR, et al. Indoleamine 2,3-dioxygenase inhibition alters the non-coding RNA transcriptome following renal ischemia-reperfusion injury. Transpl Immunol 2014;30(4):140-4
   PubMedGoogle Scholar
• Wang Y, Gao S, Liu G, et al. Microarray expression profile analysis of long non-coding RNAs in human gastric cardiac adenocarcinoma. Cell Physiol Biochem 2014;33:1225-38
   PubMedGoogle Scholar
• Slack FJ. In this issue of epigenetics: special focus on non-coding RNAs in epigenetic regulation. Epigenetics 2014;9:1-2
   PubMedGoogle Scholar
• Haga H, Yan I, Takahashi K, et al. Emerging insights into the role of MicroRNAs in the pathogenesis of cholangiocarcinoma. Gene Expr 2014;16:93-9
   PubMedGoogle Scholar
• Jeong HJ, Park SY, Yang WM, et al. The induction of miR-96 by mitochondrial dysfunction causes impaired glycogen synthesis through translational repression of IRS-1 in SK-Hep1 cells. Biochem Biophys Res Commun 2013;434:503-8
   PubMed Web of Science ®Google Scholar
• Das S, Bedja D, Campbell N, et al. miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One 2014;9:e96820
   PubMed Web of Science ®Google Scholar
• Bai Z, Huang Y, Li W, et al. Genomewide mapping and screening of Kaposi’s sarcoma-associated herpesvirus (KSHV) 3’ untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAs. J Virol 2014;88:377-92
   PubMedGoogle Scholar
• Wirsing A, Senkel S, Klein-Hitpass L, et al. A systematic analysis of the 3’UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites. PLoS One 2011;6:e27438
   Google Scholar
• Cheng TL, Wang Z, Liao Q, et al. MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex. Dev Cell 2014;28:547-60
   PubMed Web of Science ®Google Scholar
• Beisel CL, Bloom RJ, Smolke CD. Construction of ligand-responsive microRNAs that operate through inhibition of Drosha processing. Methods Mol Biol 2014;1111:259-67
   PubMedGoogle Scholar
• Iyengar BR, Choudhary A, Sarangdhar MA, et al. Non-coding RNA interact to regulate neuronal development and function. Front Cell Neurosci 2014;8:47
   PubMed Web of Science ®Google Scholar
• Hussain M, O’Neill SL, Asgari S. Wolbachia interferes with the intracellular distribution of Argonaute 1 in the dengue vector Aedes aegypti by manipulating the host microRNAs. RNA Biol 2013;10:1868-75
   PubMed Web of Science ®Google Scholar
• Flores O, Kennedy EM, Skalsky RL, et al. Differential RISC association of endogenous human microRNAs predicts their inhibitory potential. Nucleic Acids Res 2014;42:4629-39
   PubMed Web of Science ®Google Scholar
• Shi KH, Tao H, Yang JJ, et al. Role of microRNAs in atrial fibrillation: new insights and perspectives. Cell Signal 2013;25:2079-84
   PubMedGoogle Scholar
• Plank M, Maltby S, Mattes J, et al. Targeting translational control as a novel way to treat inflammatory disease: the emerging role of microRNAs. Clin Exp Allergy 2013;43:981-99
   PubMedGoogle Scholar
• Bang C, Batkai S, Dangwal S, et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 2014;124:2136-46
   PubMed Web of Science ®Google Scholar
• Chen S, Puthanveetil P, Feng B, et al. Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med 2014;18:415-21
   PubMedGoogle Scholar
• Nie FQ, Zhu Q, Xu TP, et al. Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion. Tumour Biol 2014;35(8):7587-94
   PubMedGoogle Scholar
• Matsui M, Chu Y, Zhang H, et al. Promoter RNA links transcriptional regulation of inflammatory pathway genes. Nucleic Acids Res 2013;41:10086-109
   PubMed Web of Science ®Google Scholar
• Ilott NE, Ponting CP. Predicting long non-coding RNAs using RNA sequencing. Methods 2013;63:50-9
   PubMed Web of Science ®Google Scholar
• Ng SY, Stanton LW. Long non-coding RNAs in stem cell pluripotency. Wiley Interdiscip Rev RNA 2013;4:121-8
   PubMed Web of Science ®Google Scholar
• Shore AN, Herschkowitz JI, Rosen JM. Noncoding RNAs involved in mammary gland development and tumorigenesis: there’s a long way to go. J Mammary Gland Biol Neoplasia 2012;17:43-58
   PubMed Web of Science ®Google Scholar
• Knauss JL, Sun T. Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function. Neuroscience 2013;235:200-14
   PubMed Web of Science ®Google Scholar
• Carpenter S, Aiello D, Atianand MK, et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 2013;341:789-92
   PubMed Web of Science ®Google Scholar
• Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010;142:409-19
   PubMed Web of Science ®Google Scholar
• Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329:689-93
   PubMed Web of Science ®Google Scholar
• Lorenzen JM, Martino F, Thum T. Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 2012;107:245
   PubMed Web of Science ®Google Scholar
• Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009;458:223-7
   PubMed Web of Science ®Google Scholar
• Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012;81:145-66
   PubMed Web of Science ®Google Scholar
• Necsulea A, Soumillon M, Warnefors M, et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 2014;505:635-40
   PubMed Web of Science ®Google Scholar
• Li G, Zhang H, Wan X, et al. Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma. BioMed Res Int 2014;2014:780521
   PubMed Web of Science ®Google Scholar
• Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol 2010;7:582-5
   PubMed Web of Science ®Google Scholar
• Nagano T, Mitchell JA, Sanz LA, et al. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 2008;322:1717-20
   PubMed Web of Science ®Google Scholar
• Yang IV, Schwartz DA. Epigenetic mechanisms and the development of asthma. J Allergy Clin Immunol 2012;130:1243-55
   PubMed Web of Science ®Google Scholar
• Furuta Y, Namba-Fukuyo H, Shibata TF, et al. Methylome diversification through changes in DNA methyltransferase sequence specificity. PLoS Genet 2014;10:e1004272
   Google Scholar
• Duygu B, Poels EM, da Costa Martins PA. Genetics and epigenetics of arrhythmia and heart failure. Front Genetics 2013;4:219
   PubMedGoogle Scholar
• Gray SG. Epigenetic-based immune intervention for rheumatic diseases. Epigenomics 2014;6:253-71
   PubMedGoogle Scholar
• Vincent A, Hong SM, Hu C, et al. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget 2014;5(9):2575-87
   PubMedGoogle Scholar
• Han F, Dong Y, Liu W, et al. Epigenetic regulation of sox30 is associated with testis development in mice. PLoS One 2014;9:e97203
   Google Scholar
• Teif VB, Beshnova DA, Vainshtein Y, et al. Nucleosome repositioning links DNA (de)methylation and differential CTCF binding during stem cell development. Genome Res 2014;24(8):1285-95
   Google Scholar
• Dyachenko OV, Tarlachkov SV, Marinitch DV, et al. Expression of exogenous DNA methyltransferases: application in molecular and cell biology. Biochemistry(Mosc) 2014;79:77-87
   PubMedGoogle Scholar
• Tao H, Yang JJ, Shi KH, et al. DNA methylation in cardiac fibrosis: New advances and perspectives. Toxicology 2014;323:125-9
   PubMedGoogle Scholar
• Sitaraman R. Helicobacter pylori DNA methyltransferases and the epigenetic field effect in cancerization. Front Microbiol 2014;5:115
   PubMedGoogle Scholar
• Talhaoui I, Couve S, Gros L, et al. Aberrant repair initiated by mismatch-specific thymine-DNA glycosylases provides a mechanism for the mutational bias observed in CpG islands. Nucleic Acids Res 2014;42(10):6300-13
   PubMedGoogle Scholar
• Xue J, Wijeratne SS, Zempleni J. Holocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of long-terminal repeats. Epigenetics 2013;8:504-11
   PubMed Web of Science ®Google Scholar
• Shimahara H, Hirano T, Ohya K, et al. Nucleosome structural changes induced by binding of non-histone chromosomal proteins HMGN1 and HMGN2. FEBS Open Bio 2013;3:184-91
   PubMedGoogle Scholar
• Lan L, Nakajima S, Kapetanaki MG, et al. Monoubiquitinated histone H2A destabilizes photolesion-containing nucleosomes with concomitant release of UV-damaged DNA-binding protein E3 ligase. J Biol Chem 2012;287:12036-49
   PubMed Web of Science ®Google Scholar
• Halley-Stott RP, Gurdon JB. Epigenetic memory in the context of nuclear reprogramming and cancer. Brief Funct Genomics 2013;12:164-73
   PubMed Web of Science ®Google Scholar
• Vire E, Brenner C, Deplus R, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006;439:871-4
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu K, Qin S, et al. Epigenetic targets and drug discovery: Part 1: histone methylation. Pharmacol Ther 2014;143(3):275-94
   PubMed Web of Science ®Google Scholar
• Kimura H. Histone modifications for human epigenome analysis. J Hum Genet 2013;58:439-45
   PubMed Web of Science ®Google Scholar
• Tao H, Shi KH, Yang JJ, et al. Epigenetic regulation of cardiac fibrosis. Cell Signal 2013;25:1932-8
   PubMedGoogle Scholar
• White R. Packaging the fly genome: domains and dynamics. Brief Funct Genomics 2012;11:347-55
   Google Scholar
• Glinsky GV. Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway. Cell Cycle 2006;5:1208-16
   PubMed Web of Science ®Google Scholar
• van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 2012;11:860-72
   PubMed Web of Science ®Google Scholar
• Latronico MV, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol 2009;6:419-29
   PubMed Web of Science ®Google Scholar
• Gomez GG, Wykosky J, Zanca C, et al. Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks. Cancer Biol Med 2013;10:192-205
   PubMedGoogle Scholar
• Peruzzi P, Bronisz A, Nowicki MO, et al. MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells. Neuro-oncol 2013;15:1212-24
   PubMedGoogle Scholar
• Mathiyalagan P, Okabe J, Chang L, et al. The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart. Nucleic Acids Res 2014;42:790-803
   Google Scholar
• Yang T, Zhang GF, Chen XF, et al. MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2. Biochem Biophys Res Commun 2013;436:578-84
   PubMedGoogle Scholar
• Coppola A, Romito A, Borel C, et al. Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications. Stem Cell Res 2014;12:323-37
   PubMed Web of Science ®Google Scholar
• Zhu H, Yang Y, Wang Y, et al. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res 2011;92:75-84
   PubMed Web of Science ®Google Scholar
• Huang ZP, Chen J, Seok HY, et al. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res 2013;112:1234-43
   PubMed Web of Science ®Google Scholar
• Shi H, Chen L, Wang H, et al. Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes. Biochem Biophys Res Commun 2013;430:827-32
   PubMedGoogle Scholar
• Duan Y, Zhou B, Su H, et al. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300. Exp Cell Res 2013;319:173-84
   PubMedGoogle Scholar
• Ghosh AK, Nagpal V, Covington JW, et al. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. Cell Signal 2012;24:1031-6
   PubMed Web of Science ®Google Scholar
• Chavali V, Tyagi SC, Mishra PK. MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes. Biochem Biophys Res Commun 2012;425:668-72
   PubMedGoogle Scholar
• Wamstad JA, Alexander JM, Truty RM, et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 2012;151:206-20
   PubMed Web of Science ®Google Scholar
• Zhou S, Liu Y, Prater K, et al. Roles of microRNAs in pressure overload- and ischemia-related myocardial remodeling. Life Sci 2013;93:855-62
   PubMedGoogle Scholar
• Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell 2014;157:77-94
   PubMed Web of Science ®Google Scholar
• Wang K, Liu F, Zhou LY, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res 2014;114:1377-88
   PubMed Web of Science ®Google Scholar
• Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell 2013;24:206-14
   PubMed Web of Science ®Google Scholar
• Wang K, Long B, Zhou LY, et al. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun 2014;5:3596
   PubMed Web of Science ®Google Scholar
• Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010;121:1022-32
   PubMed Web of Science ®Google Scholar
• Malecova B, Morris KV. Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs. Curr Opin Mol Ther 2010;12:214-22
   Google Scholar
• Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell 2011;145:178-81
   PubMed Web of Science ®Google Scholar
• Peschansky VJ, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics 2014;9:3-12
   PubMed Web of Science ®Google Scholar